Use access key #2 to skip to page content.
$2.41 0.02 (0.84%)
7/3/2008 1:00 PM

Cell Genesys, Inc. (CEGE)

CAPS Rating:
***

A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.

View All Commentary (CEGE)

Recs

2

Avatar cardinals18 (52.86) Submitted: 3/24/08 11:25 AM : Outperform Start Price: $2.38 CEGE Score: 7.63

Will get a partner deal done soon, also expect great news comming out of trials.

Report this Post Replies: 0 | Reply

Featured Broker Partners